Metformin promotes mitochondrial integrity through AMPK-signaling in Leber’s hereditary optic neuropathy

Leber’s hereditary optic neuropathy (LHON) is a maternally inherited disorder caused by mitochondrial DNA mutations in complex I of the respiratory chain, leading to impaired ATP production, mitochondrial fragmentation, and oxidative stress that contribute to vision loss. This study investigated the potential repurposing of metformin, a widely used antidiabetic drug, in fibroblasts from LHON patients carrying the m.11778G>A mutation. Fibroblasts from LHON patients and healthy individuals were…

In vivo mitochondrial base editing restores genotype and visual function in a mouse model of LHON

Leber hereditary optic neuropathy (LHON), a maternally inherited mitochondrial disorder, results from point mutations in mitochondrial DNA (mtDNA), primarily affecting the MT-ND4 gene. To date, no animal model harboring authentic LHON mutations has been available, limiting therapeutic development. However, when we attempted to generate such models using mitochondrial base editors, we found that activity-enhanced DddA11-based cytosine base editors (DdCBEs) induce off-target mtDNA mutations and…

From Castro to Quantum Mechanics: Marching Through Tunnels With Reactive Oxygen Species

The 2025 Jacobson Lecture revealed a scientific journey that began with the Cuban epidemic of blindness to recent studies of the quantum mechanical underpinnings of Leber’s Hereditary Optic Neuropathy (LHON). A sudden outbreak of bilaterally symmetrical optic neuropathy and peripheral neuropathy in more than 50,000 Cubans in 1993 had been blamed on a viral infection. Further investigations by our team revealed synergistic toxicity of folic acid deficiency and the consumption of homemade rum…

Super mitochondria-enriched extracellular vesicles enable enhanced mitochondria transfer

Mitochondria transfer is a spontaneous process that releases functional mitochondria to damaged cells via different mechanisms including extracellular vesicle containing mitochondria (EV-Mito) to restore mitochondrial functions. However, the limited EV-Mito yield makes it challenging to supply a sufficient quantity of functional mitochondria to damaged cells, hindering their application in mitochondrial diseases. Here, we show that the release of EV-Mito from mesenchymal stem cells (MSCs) is…

Navigating Health When Sudden Blindness Occurs: The Experience of Leber Hereditary Optic Neuropathy

Millions of Americans are affected by vision loss. Individuals diagnosed with Leber hereditary optic neuropathy face unique challenges due to the sudden and severe nature of vision loss. This genetic condition often results in difficulty obtaining a timely diagnosis and adjusting to blindness in a society primarily designed for sighted individuals. This study aimed to better understand the experiences of individuals who have severe central vision loss, particularly their interactions with the…

Development of Two In Vitro ND1-LHON Models for Evaluating Gene Therapy Efficacy

CONCLUSIONS: The study demonstrates the utility of transmitochondrial cybrids and iPSC-derived RGCs as reliable in vitro models for studying ND1-related LHON. The rAAV-ND1 gene therapy effectively restored mitochondrial function, highlighting its potential as a treatment for LHON caused by ND1 mutations. These findings underscore the value of in vitro systems for evaluating therapies when robust animal models are unavailable.